BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32312103)

  • 21. Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the
    Dols-Icardo O; García-Redondo A; Rojas-García R; Borrego-Hernández D; Illán-Gala I; Muñoz-Blanco JL; Rábano A; Cervera-Carles L; Juárez-Rufián A; Spataro N; De Luna N; Galán L; Cortes-Vicente E; Fortea J; Blesa R; Grau-Rivera O; Lleó A; Esteban-Pérez J; Gelpi E; Clarimón J
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):162-168. PubMed ID: 28889094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An improved electrical impedance myography (EIM) tongue array for use in clinical trials.
    McIlduff C; Yim S; Pacheck A; Geisbush T; Mijailovic A; Rutkove SB
    Clin Neurophysiol; 2016 Jan; 127(1):932-935. PubMed ID: 26242815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
    Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
    Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum.
    Ji AL; Zhang X; Chen WW; Huang WJ
    J Med Genet; 2017 Mar; 54(3):145-154. PubMed ID: 28087719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OPTN p.Met468Arg and ATXN2 intermediate length polyQ extension in families with C9orf72 mediated amyotrophic lateral sclerosis and frontotemporal dementia.
    Farhan SMK; Gendron TF; Petrucelli L; Hegele RA; Strong MJ
    Am J Med Genet B Neuropsychiatr Genet; 2018 Jan; 177(1):75-85. PubMed ID: 29080331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The frequency of the C9orf72 expansion in a Brazilian population.
    Cintra VP; Bonadia LC; Andrade HMT; de Albuquerque M; Eusébio MF; de Oliveira DS; Claudino R; Gonçalves MVM; Teixeira AL; de Godoy Rousseff Prado L; de Souza LC; Dourado MET; Oliveira ASB; Tumas V; França MC; Marques W
    Neurobiol Aging; 2018 Jun; 66():179.e1-179.e4. PubMed ID: 29449030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
    Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
    Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortical hyperexcitability in patients with C9ORF72 mutations: Relationship to phenotype.
    Schanz O; Bageac D; Braun L; Traynor BJ; Lehky TJ; Floeter MK
    Muscle Nerve; 2016 Aug; 54(2):264-9. PubMed ID: 26799151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C9orf72 Gene Expression in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
    Shpilyukova YA; Fedotova EY; Abramycheva NY; Kochergin IA; Zakroyshchikova IV; Zakharova MN; Illarioshkin SN
    Bull Exp Biol Med; 2020 Sep; 169(5):673-676. PubMed ID: 32990847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneous brain FDG-PET metabolic patterns in patients with C9orf72 mutation.
    Castelnovo V; Caminiti SP; Riva N; Magnani G; Silani V; Perani D
    Neurol Sci; 2019 Mar; 40(3):515-521. PubMed ID: 30554355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile.
    Devenney E; Hornberger M; Irish M; Mioshi E; Burrell J; Tan R; Kiernan MC; Hodges JR
    JAMA Neurol; 2014 Mar; 71(3):331-9. PubMed ID: 24445580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort.
    Kartanou C; Karadima G; Koutsis G; Breza M; Papageorgiou SG; Paraskevas GP; Kapaki E; Panas M
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):152-154. PubMed ID: 29166782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Amyotrophic lateral sclerosis and frontotemporal dementia-On the way to common gene-specific treatment approaches].
    Anderl-Straub S; Schuster J; Dorst J; Ludolph AC
    Nervenarzt; 2021 Dec; 92(12):1219-1226. PubMed ID: 34704111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localized muscle impedance abnormalities in amyotrophic lateral sclerosis.
    Tarulli AW; Garmirian LP; Fogerson PM; Rutkove SB
    J Clin Neuromuscul Dis; 2009 Mar; 10(3):90-6. PubMed ID: 19258856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD?
    Braems E; Swinnen B; Van Den Bosch L
    Acta Neuropathol; 2020 Nov; 140(5):625-643. PubMed ID: 32876811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All in the Family: Repeats and ALS/FTD.
    Pattamatta A; Cleary JD; Ranum LPW
    Trends Neurosci; 2018 May; 41(5):247-250. PubMed ID: 29703376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex differences in the prevalence of genetic mutations in FTD and ALS: A meta-analysis.
    Curtis AF; Masellis M; Hsiung GR; Moineddin R; Zhang K; Au B; Millett G; Mackenzie I; Rogaeva E; Tierney MC
    Neurology; 2017 Oct; 89(15):1633-1642. PubMed ID: 28916533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts.
    Le Ber I; De Septenville A; Millecamps S; Camuzat A; Caroppo P; Couratier P; Blanc F; Lacomblez L; Sellal F; Fleury MC; Meininger V; Cazeneuve C; Clot F; Flabeau O; LeGuern E; Brice A;
    Neurobiol Aging; 2015 Nov; 36(11):3116.e5-3116.e8. PubMed ID: 26476236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presymptomatic spinal cord pathology in c9orf72 mutation carriers: A longitudinal neuroimaging study.
    Querin G; Bede P; El Mendili MM; Li M; Pélégrini-Issac M; Rinaldi D; Catala M; Saracino D; Salachas F; Camuzat A; Marchand-Pauvert V; Cohen-Adad J; Colliot O; Le Ber I; Pradat PF;
    Ann Neurol; 2019 Aug; 86(2):158-167. PubMed ID: 31177556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD.
    Tang X; Toro A; T G S; Gao J; Chalk J; Oskarsson B; Zhang K
    Mol Neurodegener; 2020 Jun; 15(1):34. PubMed ID: 32513219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.